U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 2417

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr17:67205220-81044553
GRCh38:
Chr17:69209079-83086677
AANAT, AATK, ABCA10, ABCA5, ACOX1, ACTG1, AFMID, ALYREF, ANAPC11, ARHGDIA, ARL16, ARMC7, ASPSCR1, ATP5PD, B3GNTL1, BAHCC1, BAIAP2, BAIAP2-DT, BIRC5, BTBD17, C17orf80, C17orf99, C1QTNF1, C1QTNF1-AS1, CANT1, CARD14, CASC17, CASKIN2, CBX2, CBX4, CBX8, CCDC137, CCDC40, CCDC57, CD300A, CD300C, CD300E, CD300H, CD300LB, CD300LD, CD300LD-AS1, CD300LF, CD7, CDC42EP4, CDK3, CDR2L, CENPX, CEP131, CEP295NL, CHMP6, COG1, CPSF4L, CSNK1D, CYBC1, CYGB, CYTH1, DCXR, DCXR-DT, DNAH17, DNAH17-AS1, DNAI2, DUS1L, EIF4A3, ENDOV, ENGASE, ENPP7, EVPL, EXOC7, FAAP100, FADS6, FAM104A, FASN, FBF1, FDXR, FN3K, FN3KRP, FOXJ1, FOXK2, FSCN2, GAA, GALK1, GALR2, GCGR, GGA3, GPR142, GPRC5C, GPS1, GRB2, GRIN2C, H3-3B, HEXD, HEXD-IT1, HGS, HID1, HID1-AS1, ITGB4, JMJD6, JPT1, KCNJ16, KCNJ2, KCNJ2-AS1, KCTD2, KIF19, LGALS3BP, LINC00469, LINC00482, LINC00511, LINC00673, LINC00868, LINC01028, LINC01152, LINC01483, LINC01497, LINC01970, LINC01971, LINC01973, LINC01977, LINC01978, LINC01979, LINC01987, LINC01993, LINC02003, LINC02074, LINC02078, LINC02080, LINC02092, LINC02097, LINC03048, LLGL2, LOC100134391, LOC100507351, LOC101928251, LOC101928343, LOC101928855, LOC101929552, LOC102723517, LOC105274304, LOC105371880, LOC105371899, LOC105371910, LOC105371925, LOC108004545, LOC108004546, LOC108004547, LOC108004548, LOC108004549, LOC108004550, LOC108021839, LOC108021840, LOC108021842, LOC108021843, LOC108021844, LOC108021845, LOC108021846, LOC108254686, LOC108254691, LOC108281162, LOC108348028, LOC110121373, LOC110599586, LOC111413039, LOC111429614, LOC112268198, LOC112533666, LOC112533667, LOC112533668, LOC112533669, LOC112533670, LOC112533671, LOC112533672, LOC112533673, LOC112533674, LOC112533675, LOC112533676, LOC112533677, LOC112533678, LOC112533679, LOC112533680, LOC112533681, LOC112533682, LOC112533686, LOC112533687, LOC116276479, LOC116276480, LOC116276481, LOC116276482, LOC116276483, LOC116276484, LOC116276485, LOC121603772, LOC121603773, LOC121627807, LOC121627808, LOC121627809, LOC121627810, LOC121627811, LOC121627812, LOC121627813, LOC121627814, LOC121627815, LOC121627816, LOC121627817, LOC121627818, LOC121627819, LOC121627820, LOC121852949, LOC121852950, LOC121852951, LOC121852952, LOC121852953, LOC121852954, LOC121852955, LOC121852956, LOC121852957, LOC122455342, LOC125316786, LOC125316787, LOC125316788, LOC125316789, LOC125316790, LOC125316791, LOC125316792, LOC125316793, LOC125316794, LOC125316795, LOC125316796, LOC125316797, LOC125316798, LOC125316799, LOC125316800, LOC125316801, LOC125316802, LOC125316804, LOC125316805, LOC125316806, LOC125316807, LOC125316808, LOC125316809, LOC125316810, LOC125316811, LOC125316812, LOC125316813, LOC125316814, LOC125316815, LOC125316816, LOC125316817, LOC125316818, LOC125316819, LOC125316821, LOC125316822, LOC125316823, LOC126862624, LOC126862625, LOC126862626, LOC126862627, LOC126862628, LOC126862629, LOC126862630, LOC126862631, LOC126862632, LOC126862633, LOC126862634, LOC126862635, LOC126862636, LOC126862637, LOC126862638, LOC126862639, LOC126862640, LOC126862641, LOC126862642, LOC126862643, LOC126862644, LOC126862645, LOC126862646, LOC126862647, LOC126862648, LOC126862649, LOC126862650, LOC126862651, LOC126862652, LOC126862653, LOC126862654, LOC126862655, LOC126862656, LOC126862657, LOC126862658, LOC126862659, LOC126862660, LOC126862661, LOC126862662, LOC126862663, LOC126862664, LOC126862665, LOC126862666, LOC126862667, LOC126862668, LOC126862669, LOC126862670, LOC126862671, LOC126862672, LOC126862673, LOC126862674, LOC400622, LOC400627, LRRC45, MAFG, MAP2K6, MCRIP1, METRNL, METTL23, MFSD11, MGAT5B, MGC16275, MIF4GD, MIF4GD-DT, MILIP, MIR1250, MIR1268B, MIR3065, MIR3186, MIR338, MIR3615, MIR3678, MIR4316, MIR4525, MIR4730, MIR4738, MIR4739, MIR4740, MIR636, MIR6516, MIR657, MIR6785, MIR6786, MIR6787, MIR6868, MRPL12, MRPL38, MRPL58, MRPS7, MXRA7, MYADML2, MYO15B, NARF, NARF-AS2, NAT9, NDUFAF8, NHERF1, NOTUM, NPB, NPLOC4, NPTX1, NT5C, NUP85, OGFOD3, OTOP2, OTOP3, OXLD1, P4HB, PCYT2, PDE6G, PGS1, PPP1R27, PRCD, PRO1804, PRPSAP1, PVALEF, PYCR1, QRICH2, RAB37, RAB40B, RAC3, RBFOX3, RECQL5, RFNG, RHBDF2, RNF157, RNF157-AS1, RNF213, RNF213-AS1, ROCR, RPL38, RPTOR, SAP30BP, SCARNA16, SCAT1, SDK2, SEC14L1, SECTM1, SEPTIN9, SEPTIN9-DT, SGSH, SIRT7, SLC16A3, SLC16A5, SLC25A10, SLC25A19, SLC26A11, SLC38A10, SLC39A11, SLC9A3R1-AS1, SMIM5, SMIM6, SNHG16, SNHG20, SNORD134, SNORD1A, SNORD1B, SNORD1C, SOCS3, SOCS3-DT, SOX9, SOX9-AS1, SOX9CRE1, SPHK1, SRP68, SRSF2, SSTR2, ST6GALNAC1, ST6GALNAC2, SUMO2, SYNGR2, TBC1D16, TBCD, TEN1, TEN1-CDK3, TEPSIN, TEX19, TIMP2, TK1, TMC6, TMC8, TMEM104, TMEM105, TMEM235, TMEM94, TNRC6C, TNRC6C-AS1, TRIM47, TRIM65, TRR-CCT1-1, TRR-CCT2-1, TRR-TCG3-1, TRX-CAT1-8, TSEN54, TSPAN10, TTYH2, UBALD2, UBE2O, UNC13D, UNK, USH1G, USP36, UTS2R, WBP2, WDR45B, ZACN, ZNF750
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
2.
GRCh37:
Chr17:67912576-81048189
GRCh38:
Chr17:69916435-83102552
GALK1, GALR2, GCGR, GGA3, GPR142, GPRC5C, GPS1, GRB2, GRIN2C, H3-3B, HEXD, HEXD-IT1, HGS, HID1, HID1-AS1, ITGB4, JMJD6, JPT1, KCNJ16, KCNJ2, KCNJ2-AS1, KCTD2, KIF19, LGALS3BP, LINC00469, LINC00482, LINC00511, LINC00673, LINC00868, LINC01028, LINC01152, LINC01497, LINC01970, LINC01971, LINC01973, LINC01977, LINC01978, LINC01979, LINC01987, LINC01993, LINC02003, LINC02074, LINC02078, LINC02080, LINC02092, LINC02097, LINC03048, LLGL2, LOC100134391, LOC100507351, LOC101928251, LOC101928343, LOC101928855, LOC101929552, LOC102723517, LOC105274304, LOC105371899, LOC105371910, LOC105371925, LOC108004545, LOC108004546, LOC108004547, LOC108004548, LOC108004549, LOC108004550, LOC108021839, LOC108021840, LOC108021842, LOC108021843, LOC108021844, LOC108021845, LOC108021846, LOC108254686, LOC108254691, LOC108281162, LOC108348028, LOC110121373, LOC110599586, LOC111413039, LOC111429614, LOC112268198, LOC112533666, LOC112533667, LOC112533668, LOC112533669, LOC112533670, LOC112533671, LOC112533672, LOC112533673, LOC112533674, LOC112533675, LOC112533676, LOC112533677, LOC112533678, LOC112533679, LOC112533680, LOC112533681, LOC112533682, LOC112533686, LOC112533687, LOC116276479, LOC116276480, LOC116276481, LOC116276482, LOC116276483, LOC116276484, LOC116276485, LOC121603772, LOC121603773, LOC121627807, LOC121627808, LOC121627809, LOC121627810, LOC121627811, LOC121627812, LOC121627813, LOC121627814, LOC121627815, LOC121627816, LOC121627817, LOC121627818, LOC121627819, LOC121627820, LOC121852949, LOC121852950, LOC121852951, LOC121852952, LOC121852953, LOC121852954, LOC121852955, LOC121852956, LOC121852957, LOC122455342, LOC125316787, LOC125316788, LOC125316789, LOC125316790, LOC125316791, LOC125316792, LOC125316793, LOC125316794, LOC125316795, LOC125316796, LOC125316797, LOC125316798, LOC125316799, LOC125316800, LOC125316801, LOC125316802, LOC125316804, LOC125316805, LOC125316806, LOC125316807, LOC125316808, LOC125316809, LOC125316810, LOC125316811, LOC125316812, LOC125316813, LOC125316814, LOC125316815, LOC125316816, LOC125316817, LOC125316818, LOC125316819, LOC125316821, LOC125316822, LOC125316823, LOC126862626, LOC126862627, LOC126862628, LOC126862629, LOC126862630, LOC126862631, LOC126862632, LOC126862633, LOC126862634, LOC126862635, LOC126862636, LOC126862637, LOC126862638, LOC126862639, LOC126862640, LOC126862641, LOC126862642, LOC126862643, LOC126862644, LOC126862645, LOC126862646, LOC126862647, LOC126862648, LOC126862649, LOC126862650, LOC126862651, LOC126862652, LOC126862653, LOC126862654, LOC126862655, LOC126862656, LOC126862657, LOC126862658, LOC126862659, LOC126862660, LOC126862661, LOC126862662, LOC126862663, LOC126862664, LOC126862665, LOC126862666, LOC126862667, LOC126862668, LOC126862669, LOC126862670, LOC126862671, LOC126862672, LOC126862673, LOC126862674, LOC400622, LOC400627, LRRC45, MAFG, MCRIP1, METRNL, METTL23, MFSD11, MGAT5B, MGC16275, MIF4GD, MIF4GD-DT, MILIP, MIR1250, MIR1268B, MIR3065, MIR3186, MIR338, MIR3615, MIR3678, MIR4316, MIR4525, MIR4730, MIR4738, MIR4739, MIR4740, MIR636, MIR6516, MIR657, MIR6785, MIR6786, MIR6787, MIR6868, MRPL12, MRPL38, MRPL58, MRPS7, MXRA7, MYADML2, MYO15B, NARF, NARF-AS2, NAT9, NDUFAF8, NHERF1, NOTUM, NPB, NPLOC4, NPTX1, NT5C, NUP85, OGFOD3, OTOP2, OTOP3, OXLD1, P4HB, PCYT2, PDE6G, PGS1, PPP1R27, PRCD, PRPSAP1, PVALEF, PYCR1, QRICH2, RAB37, RAB40B, RAC3, RBFOX3, RECQL5, RFNG, RHBDF2, RNF157, RNF157-AS1, RNF213, RNF213-AS1, ROCR, RPL38, RPTOR, SAP30BP, SCARNA16, SCAT1, SDK2, SEC14L1, SECTM1, SEPTIN9, SEPTIN9-DT, SGSH, SIRT7, SLC16A3, SLC16A5, SLC25A10, SLC25A19, SLC26A11, SLC38A10, SLC39A11, SLC9A3R1-AS1, SMIM5, SMIM6, SNHG16, SNHG20, SNORD134, SNORD1A, SNORD1B, SNORD1C, SOCS3, SOCS3-DT, SOX9, SOX9-AS1, SOX9CRE1, SPHK1, SRP68, SRSF2, SSTR2, ST6GALNAC1, ST6GALNAC2, SUMO2, SYNGR2, TBC1D16, TBCD, TEN1, TEN1-CDK3, TEPSIN, TEX19, TIMP2, TK1, TMC6, TMC8, TMEM104, TMEM105, TMEM235, TMEM94, TNRC6C, TNRC6C-AS1, TRIM47, TRIM65, TRR-CCT1-1, TRR-CCT2-1, TRR-TCG3-1, TRX-CAT1-8, TSEN54, TSPAN10, TTYH2, UBALD2, UBE2O, UNC13D, UNK, USH1G, USP36, UTS2R, WBP2, WDR45B, ZACN, ZNF750, AANAT, AATK, ACOX1, ACTG1, AFMID, ALYREF, ANAPC11, ARHGDIA, ARL16, ARMC7, ASPSCR1, ATP5PD, B3GNTL1, BAHCC1, BAIAP2, BAIAP2-DT, BIRC5, BTBD17, C17orf80, C17orf99, C1QTNF1, C1QTNF1-AS1, CANT1, CARD14, CASC17, CASKIN2, CBX2, CBX4, CBX8, CCDC137, CCDC40, CCDC57, CD300A, CD300C, CD300E, CD300H, CD300LB, CD300LD, CD300LD-AS1, CD300LF, CD7, CDC42EP4, CDK3, CDR2L, CENPX, CEP131, CEP295NL, CHMP6, COG1, CPSF4L, CSNK1D, CYBC1, CYGB, CYTH1, DCXR, DCXR-DT, DNAH17, DNAH17-AS1, DNAI2, DUS1L, EIF4A3, ENDOV, ENGASE, ENPP7, EVPL, EXOC7, FAAP100, FADS6, FAM104A, FASN, FBF1, FDXR, FN3K, FN3KRP, FOXJ1, FOXK2, FSCN2, GAA
See casesPathogenic
(Oct 23, 2012)
no assertion criteria provided
3.
GRCh37:
Chr17:76088317-81044553
GRCh38:
Chr17:78092236-83086677
AATK, ACTG1, AFMID, ALYREF, ANAPC11, ARHGDIA, ARL16, ASPSCR1, B3GNTL1, BAHCC1, BAIAP2, BAIAP2-DT, BIRC5, C17orf99, C1QTNF1, C1QTNF1-AS1, CANT1, CARD14, CBX2, CBX4, CBX8, CCDC137, CCDC40, CCDC57, CD7, CENPX, CEP131, CEP295NL, CHMP6, CSNK1D, CYBC1, CYTH1, DCXR, DCXR-DT, DNAH17, DNAH17-AS1, DUS1L, EIF4A3, ENDOV, ENGASE, ENPP7, FAAP100, FASN, FN3K, FN3KRP, FOXK2, FSCN2, GAA, GCGR, GPS1, HEXD, HEXD-IT1, HGS, LGALS3BP, LINC00482, LINC01970, LINC01971, LINC01977, LINC01978, LINC01979, LINC01993, LINC02078, LINC03048, LOC101928855, LOC101929552, LOC105371910, LOC105371925, LOC108254691, LOC108281162, LOC108348028, LOC110599586, LOC112533674, LOC112533675, LOC112533676, LOC112533677, LOC112533678, LOC112533679, LOC112533680, LOC112533681, LOC112533682, LOC112533686, LOC112533687, LOC116276480, LOC116276481, LOC116276482, LOC116276483, LOC116276484, LOC116276485, LOC121627814, LOC121627815, LOC121627816, LOC121627817, LOC121627818, LOC121627819, LOC121627820, LOC121852953, LOC121852954, LOC121852955, LOC121852956, LOC121852957, LOC125316806, LOC125316807, LOC125316808, LOC125316809, LOC125316810, LOC125316811, LOC125316812, LOC125316813, LOC125316814, LOC125316815, LOC125316816, LOC125316817, LOC125316818, LOC125316819, LOC125316821, LOC125316822, LOC125316823, LOC126862653, LOC126862654, LOC126862655, LOC126862656, LOC126862657, LOC126862658, LOC126862659, LOC126862660, LOC126862661, LOC126862662, LOC126862663, LOC126862664, LOC126862665, LOC126862666, LOC126862667, LOC126862668, LOC126862669, LOC126862670, LOC126862671, LOC126862672, LOC126862673, LOC126862674, LOC400627, LRRC45, MAFG, MCRIP1, METRNL, MILIP, MIR1250, MIR1268B, MIR3065, MIR3186, MIR338, MIR4525, MIR4730, MIR4739, MIR4740, MIR657, MIR6786, MIR6787, MRPL12, MYADML2, NARF, NARF-AS2, NDUFAF8, NOTUM, NPB, NPLOC4, NPTX1, OGFOD3, OXLD1, P4HB, PCYT2, PDE6G, PGS1, PPP1R27, PVALEF, PYCR1, RAB40B, RAC3, RBFOX3, RFNG, RNF213, RNF213-AS1, RPTOR, SCAT1, SECTM1, SGSH, SIRT7, SLC16A3, SLC25A10, SLC26A11, SLC38A10, SNORD134, SOCS3, SOCS3-DT, SYNGR2, TBC1D16, TBCD, TEPSIN, TEX19, TIMP2, TK1, TMC6, TMC8, TMEM105, TMEM235, TNRC6C, TNRC6C-AS1, TRX-CAT1-8, TSPAN10, USP36, UTS2R, WDR45B, ZNF750
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
4.
GRCh37:
Chr17:76898041-81044553
GRCh38:
Chr17:78901959-83086677
AATK, ACTG1, ALYREF, ANAPC11, ARHGDIA, ARL16, ASPSCR1, B3GNTL1, BAHCC1, BAIAP2, BAIAP2-DT, C1QTNF1, C1QTNF1-AS1, CANT1, CARD14, CBX2, CBX4, CBX8, CCDC137, CCDC40, CCDC57, CD7, CENPX, CEP131, CEP295NL, CHMP6, CSNK1D, CYBC1, DCXR, DCXR-DT, DUS1L, EIF4A3, ENDOV, ENGASE, ENPP7, FAAP100, FASN, FN3K, FN3KRP, FOXK2, FSCN2, GAA, GCGR, GPS1, HEXD, HEXD-IT1, HGS, LGALS3BP, LINC00482, LINC01970, LINC01971, LINC01977, LINC01978, LINC01979, LINC02078, LINC03048, LOC101928855, LOC101929552, LOC105371925, LOC108254691, LOC108281162, LOC108348028, LOC112533676, LOC112533677, LOC112533678, LOC112533679, LOC112533680, LOC112533681, LOC112533682, LOC112533686, LOC112533687, LOC116276483, LOC116276484, LOC116276485, LOC121627816, LOC121627817, LOC121627818, LOC121627819, LOC121627820, LOC121852953, LOC121852954, LOC121852955, LOC121852956, LOC121852957, LOC125316808, LOC125316809, LOC125316810, LOC125316811, LOC125316812, LOC125316813, LOC125316814, LOC125316815, LOC125316816, LOC125316817, LOC125316818, LOC125316819, LOC125316821, LOC125316822, LOC125316823, LOC126862658, LOC126862659, LOC126862660, LOC126862661, LOC126862662, LOC126862663, LOC126862664, LOC126862665, LOC126862666, LOC126862667, LOC126862668, LOC126862669, LOC126862670, LOC126862671, LOC126862672, LOC126862673, LOC126862674, LOC400627, LRRC45, MAFG, MCRIP1, METRNL, MILIP, MIR1250, MIR1268B, MIR3065, MIR3186, MIR338, MIR4525, MIR4730, MIR4739, MIR4740, MIR657, MIR6786, MIR6787, MRPL12, MYADML2, NARF, NARF-AS2, NDUFAF8, NOTUM, NPB, NPLOC4, NPTX1, OGFOD3, OXLD1, P4HB, PCYT2, PDE6G, PPP1R27, PVALEF, PYCR1, RAB40B, RAC3, RBFOX3, RFNG, RNF213, RNF213-AS1, RPTOR, SECTM1, SGSH, SIRT7, SLC16A3, SLC25A10, SLC26A11, SLC38A10, SNORD134, TBC1D16, TBCD, TEPSIN, TEX19, TIMP2, TMEM105, TRX-CAT1-8, TSPAN10, UTS2R, WDR45B, ZNF750
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
5.
GRCh37:
Chr17:76914732-80978971
GRCh38:
Chr17:78918650-83021095
SLC26A11, SLC38A10, SNORD134, TBC1D16, TBCD, TEPSIN, TEX19, TIMP2, TMEM105, TRX-CAT1-8, TSPAN10, UTS2R, WDR45B, ZNF750, AATK, ACTG1, ALYREF, ANAPC11, ARHGDIA, ARL16, ASPSCR1, B3GNTL1, BAHCC1, BAIAP2, BAIAP2-DT, C1QTNF1, C1QTNF1-AS1, CANT1, CARD14, CBX2, CBX4, CBX8, CCDC137, CCDC40, CCDC57, CD7, CENPX, CEP131, CHMP6, CSNK1D, CYBC1, DCXR, DCXR-DT, DUS1L, EIF4A3, ENDOV, ENGASE, ENPP7, FAAP100, FASN, FN3K, FN3KRP, FOXK2, FSCN2, GAA, GCGR, GPS1, HEXD, HEXD-IT1, HGS, LGALS3BP, LINC00482, LINC01970, LINC01971, LINC01977, LINC01978, LINC01979, LINC02078, LINC03048, LOC101928855, LOC101929552, LOC105371925, LOC108254691, LOC108281162, LOC108348028, LOC112533676, LOC112533677, LOC112533678, LOC112533679, LOC112533680, LOC112533681, LOC112533682, LOC112533686, LOC112533687, LOC116276483, LOC116276484, LOC116276485, LOC121627816, LOC121627817, LOC121627818, LOC121627819, LOC121627820, LOC121852953, LOC121852954, LOC121852955, LOC121852956, LOC121852957, LOC125316808, LOC125316809, LOC125316810, LOC125316811, LOC125316812, LOC125316813, LOC125316814, LOC125316815, LOC125316816, LOC125316817, LOC125316818, LOC125316819, LOC125316821, LOC125316822, LOC125316823, LOC126862658, LOC126862659, LOC126862660, LOC126862661, LOC126862662, LOC126862663, LOC126862664, LOC126862665, LOC126862666, LOC126862667, LOC126862668, LOC126862669, LOC126862670, LOC126862671, LOC126862672, LOC126862673, LOC126862674, LOC400627, LRRC45, MAFG, MCRIP1, MILIP, MIR1250, MIR1268B, MIR3065, MIR3186, MIR338, MIR4525, MIR4730, MIR4739, MIR4740, MIR657, MIR6786, MIR6787, MRPL12, MYADML2, NARF, NARF-AS2, NDUFAF8, NOTUM, NPB, NPLOC4, NPTX1, OGFOD3, OXLD1, P4HB, PCYT2, PDE6G, PPP1R27, PVALEF, PYCR1, RAB40B, RAC3, RBFOX3, RFNG, RNF213, RNF213-AS1, RPTOR, SECTM1, SGSH, SIRT7, SLC16A3, SLC25A10
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
6.
GRCh37:
Chr17:78071052
GRCh38:
Chr17:80097253
CCDC40, GAAnot specified, not provided, Glycogen storage disease, type II,
Primary ciliary dyskinesia, Primary ciliary dyskinesia 15
Benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr17:78073355
GRCh38:
Chr17:80099556
CCDC40, GAAnot specified, not provided, Primary ciliary dyskinesia,
Primary ciliary dyskinesia 15, Glycogen storage disease, type II
Benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr17:78073357
GRCh38:
Chr17:80099558
CCDC40, GAAR1071HPrimary ciliary dyskinesia 15, Glycogen storage disease, type IIUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
9.
GRCh37:
Chr17:78073485
GRCh38:
Chr17:80099686
GAA, CCDC40V1114Mnot specified, not provided, Glycogen storage disease, type II,
Primary ciliary dyskinesia, Primary ciliary dyskinesia 15
Benign/Likely benign
(Oct 28, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr17:78073562
GRCh38:
Chr17:80099763
CCDC40, GAAnot provided, Primary ciliary dyskinesia, Glycogen storage disease, type II,
not specified, Primary ciliary dyskinesia 15
Benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr17:78073589
GRCh38:
Chr17:80099790
GAA, CCDC40not specified, not provided, Primary ciliary dyskinesia,
Primary ciliary dyskinesia 15, Glycogen storage disease, type II
Benign
(Jul 14, 2021)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr17:78073723
GRCh38:
Chr17:80099924
CCDC40, GAAPrimary ciliary dyskinesia, Primary ciliary dyskinesia 15, not provided,
Glycogen storage disease, type II
Benign
(Jul 9, 2018)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr17:78073760
GRCh38:
Chr17:80099961
CCDC40, GAAPrimary ciliary dyskinesia, Primary ciliary dyskinesia 15, not provided,
Glycogen storage disease, type II
Benign
(Jul 9, 2018)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr17:78073839
GRCh38:
Chr17:80100040
CCDC40, GAAPrimary ciliary dyskinesia 15, not provided, Primary ciliary dyskinesia,
Glycogen storage disease, type II
Benign/Likely benign
(Dec 31, 2018)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr17:78074228
GRCh38:
Chr17:80100429
CCDC40, GAAPrimary ciliary dyskinesia, Primary ciliary dyskinesia 15, Glycogen storage disease, type II
Benign/Likely benign
(Jan 12, 2018)
criteria provided, single submitter
16.
GRCh37:
Chr17:78075228
GRCh38:
Chr17:80101429
GAAnot providedBenign
(Jun 29, 2018)
criteria provided, single submitter
17.
GRCh37:
Chr17:78075247
GRCh38:
Chr17:80101448
GAAnot providedLikely benign
(Aug 10, 2020)
criteria provided, single submitter
18.
GRCh37:
Chr17:78075361
GRCh38:
Chr17:80101562
GAAnot providedLikely benign
(Aug 22, 2021)
criteria provided, single submitter
19.
GRCh37:
Chr17:78075384
GRCh38:
Chr17:80101585
CCDC40, GAAnot provided, Primary ciliary dyskinesia, Glycogen storage disease, type II
Benign/Likely benign
(May 12, 2021)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr17:78075397
GRCh38:
Chr17:80101598
CCDC40, GAAPrimary ciliary dyskinesia 15, Glycogen storage disease, type IIUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
21.
GRCh37:
Chr17:78075405
GRCh38:
Chr17:80101606
GAAnot specifiedLikely benign
(Dec 11, 2017)
criteria provided, single submitter
22.
GRCh37:
Chr17:78075410
GRCh38:
Chr17:80101611
GAAnot specified, Glycogen storage disease, type IIConflicting interpretations of pathogenicity
(Jan 22, 2020)
criteria provided, conflicting interpretations
23.
GRCh37:
Chr17:78075438
GRCh38:
Chr17:80101639
GAAnot specifiedLikely benign
(May 8, 2017)
criteria provided, single submitter
24.
GRCh37:
Chr17:78075462
GRCh38:
Chr17:80101663
GAA, CCDC40Primary ciliary dyskinesia, not provided, Glycogen storage disease, type II
Benign/Likely benign
(Jun 29, 2018)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr17:78075486
GRCh38:
Chr17:80101687
GAAGlycogen storage disease, type IIUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
26.
GRCh37:
Chr17:78075544
GRCh38:
Chr17:80101745
CCDC40, GAAnot provided, Primary ciliary dyskinesia, Glycogen storage disease, type II
Benign/Likely benign
(May 12, 2021)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr17:78075606
GRCh38:
Chr17:80101807
GAAnot provided, Glycogen storage disease, type IIConflicting interpretations of pathogenicity
(May 13, 2021)
criteria provided, conflicting interpretations
28.
GRCh37:
Chr17:78075618
GRCh38:
Chr17:80101819
GAAnot specifiedLikely benign
(Jan 26, 2017)
criteria provided, single submitter
29.
GRCh37:
Chr17:78075619
GRCh38:
Chr17:80101820
GAAnot providedLikely benign
(Jun 5, 2018)
criteria provided, single submitter
30.
GRCh37:
Chr17:78075647
GRCh38:
Chr17:80101848
CCDC40, GAAnot provided, Primary ciliary dyskinesia 15, Glycogen storage disease, type II
Likely benign
(Mar 17, 2021)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr17:78075660
GRCh38:
Chr17:80101861
GAAGlycogen storage disease, type IIUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
32.
GRCh37:
Chr17:78075685
GRCh38:
Chr17:80101886
GAAnot specifiedLikely benign
(Oct 7, 2016)
criteria provided, single submitter
33.
GRCh37:
Chr17:78075706
GRCh38:
Chr17:80101907
GAAnot specifiedLikely benign
(Mar 1, 2017)
criteria provided, single submitter
34.
GRCh37:
Chr17:78075908
GRCh38:
Chr17:80102109
GAAnot providedBenign
(Jul 3, 2018)
criteria provided, single submitter
35.
GRCh37:
Chr17:78078173
GRCh38:
Chr17:80104374
GAAnot providedLikely benign
(Jun 16, 2018)
criteria provided, single submitter
36.
GRCh37:
Chr17:78078270
GRCh38:
Chr17:80104471
GAAnot providedLikely benign
(Jul 14, 2018)
criteria provided, single submitter
37.
GRCh37:
Chr17:78078336
GRCh38:
Chr17:80104537
GAAGlycogen storage disease type II, infantileUncertain significance
(Feb 19, 2019)
criteria provided, single submitter
38.
GRCh37:
Chr17:78078337-78078344
GRCh38:
Chr17:80104538-80104545
GAAGlycogen storage disease, type IILikely pathogenic
(Oct 6, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr17:78078341
GRCh38:
Chr17:80104542
GAAnot specified, Glycogen storage disease, type IIUncertain significance
(Feb 11, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr17:78078341-78093140
GRCh38:
Chr17:80104542-80119341
GAAGlycogen storage disease, type IIUncertain significance
(Oct 29, 2019)
criteria provided, single submitter
41.
GRCh37:
Chr17:78078341-78093150
GRCh38:
Chr17:80104542-80119351
GAAGlycogen storage disease, type IIUncertain significance
(Oct 14, 2019)
criteria provided, single submitter
42.
GRCh37:
Chr17:78078341-78079713
GRCh38:
Chr17:80104542-80105914
GAAGlycogen storage disease, type IIPathogenic
(Jul 25, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr17:78078341
GRCh38:
Chr17:80104542
GAACardiovascular phenotype, Inborn genetic diseases, Glycogen storage disease due to acid maltase deficiency, late-onset,
not provided, Glycogen storage disease, type IV, Myopathy,
Glycogen storage disease, type II
Pathogenic
(Jan 11, 2023)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr17:78078349
GRCh38:
Chr17:80104550
GAAnot providedUncertain significance
(Sep 9, 2019)
criteria provided, single submitter
45.
GRCh37:
Chr17:78078349
GRCh38:
Chr17:80104550
GAAnot providedLikely benign
(Jun 7, 2018)
criteria provided, single submitter
46.
GRCh37:
Chr17:78078350
GRCh38:
Chr17:80104551
GAAnot specifiedLikely benign
(Feb 11, 2016)
criteria provided, single submitter
47.
GRCh37:
Chr17:78078351
GRCh38:
Chr17:80104552
GAAGlycogen storage disease, type IIUncertain significance
(Jan 2, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr17:78078351
GRCh38:
Chr17:80104552
GAAGlycogen storage disease, type IIUncertain significance
(Jan 18, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr17:78078351
GRCh38:
Chr17:80104552
GAAGlycogen storage disease, type IIPathogenic/Likely pathogenic
(Jul 5, 2022)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr17:78078352
GRCh38:
Chr17:80104553
GAAGlycogen storage disease, type IIPathogenic/Likely pathogenic
(Feb 28, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr17:78078353
GRCh38:
Chr17:80104554
GAAGlycogen storage disease, type IILikely pathogenic
(Jan 24, 2020)
reviewed by expert panel
FDA Recognized Database
52.
GRCh37:
Chr17:78078368
GRCh38:
Chr17:80104569
GAAnot providedLikely benign
(Dec 7, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr17:78078377
GRCh38:
Chr17:80104578
GAAnot providedLikely benign
(Jun 19, 2018)
criteria provided, single submitter
54.
GRCh37:
Chr17:78078384
GRCh38:
Chr17:80104585
GAAnot specified, not providedBenign/Likely benign
(Jul 30, 2020)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr17:78078386
GRCh38:
Chr17:80104587
GAAM1LGlycogen storage disease, type IILikely pathogenic
(Jun 16, 2020)
reviewed by expert panel
FDA Recognized Database
56.
GRCh37:
Chr17:78078386
GRCh38:
Chr17:80104587
GAAM1VGlycogen storage disease, type IIPathogenic/Likely pathogenic
(May 5, 2022)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr17:78078387
GRCh38:
Chr17:80104588
GAAM1TGlycogen storage disease, type IILikely pathogenic
(Jun 16, 2020)
reviewed by expert panel
FDA Recognized Database
58.
GRCh37:
Chr17:78078388-78078389
GRCh38:
Chr17:80104589-80104590
GAAnot providedPathogenic
(Oct 22, 2019)
criteria provided, single submitter
59.
GRCh37:
Chr17:78078388
GRCh38:
Chr17:80104589
GAAM1IGlycogen storage disease, type IILikely pathogenic
(Jun 12, 2021)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr17:78078389
GRCh38:
Chr17:80104590
GAAG2*Glycogen storage disease, type IILikely pathogenic
(Mar 10, 2023)
reviewed by expert panel
FDA Recognized Database
61.
GRCh37:
Chr17:78078390
GRCh38:
Chr17:80104591
GAAG2AGlycogen storage disease, type II, not providedUncertain significance
(Feb 10, 2022)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr17:78078393
GRCh38:
Chr17:80104594
GAAV3AGlycogen storage disease, type IIUncertain significance
(Sep 1, 2021)
criteria provided, single submitter
63.
GRCh37:
Chr17:78078396
GRCh38:
Chr17:80104597
GAAR4Knot provided, Glycogen storage disease, type IIUncertain significance
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr17:78078401
GRCh38:
Chr17:80104602
GAAP6SGlycogen storage disease, type IIUncertain significance
(Sep 24, 2021)
criteria provided, single submitter
65.
GRCh37:
Chr17:78078402
GRCh38:
Chr17:80104603
GAAP6QGlycogen storage disease, type IIUncertain significance
(Mar 23, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr17:78078402
GRCh38:
Chr17:80104603
GAAP6Lnot provided, Glycogen storage disease, type IIUncertain significance
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr17:78078403
GRCh38:
Chr17:80104604
GAAnot provided, Glycogen storage disease, type IIConflicting interpretations of pathogenicity
(Jun 22, 2022)
criteria provided, conflicting interpretations
68.
GRCh37:
Chr17:78078403
GRCh38:
Chr17:80104604
GAAnot provided, Glycogen storage disease, type IIConflicting interpretations of pathogenicity
(Feb 5, 2022)
criteria provided, conflicting interpretations
69.
GRCh37:
Chr17:78078406
GRCh38:
Chr17:80104607
GAAGlycogen storage disease, type IILikely benign
(Jun 20, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr17:78078409
GRCh38:
Chr17:80104610
GAAGlycogen storage disease, type IILikely benign
(Aug 7, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr17:78078410
GRCh38:
Chr17:80104611
GAAS9Pnot providedUncertain significance
(Oct 2, 2015)
criteria provided, single submitter
72.
GRCh37:
Chr17:78078411
GRCh38:
Chr17:80104612
GAAS9FGlycogen storage disease, type IIUncertain significance
(Sep 1, 2021)
criteria provided, single submitter
73.
GRCh37:
Chr17:78078411
GRCh38:
Chr17:80104612
GAAS9Cnot providedUncertain significance
(Jun 1, 2016)
criteria provided, single submitter
74.
GRCh37:
Chr17:78078416
GRCh38:
Chr17:80104617
GAAR11WGlycogen storage disease, type IIUncertain significance
(Jul 12, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr17:78078416
GRCh38:
Chr17:80104617
GAAR11GGlycogen storage disease, type IIUncertain significance
(Aug 26, 2021)
criteria provided, single submitter
76.
GRCh37:
Chr17:78078417
GRCh38:
Chr17:80104618
GAAR11LGlycogen storage disease, type IIUncertain significance
(Jun 9, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr17:78078417
GRCh38:
Chr17:80104618
GAAR11Qnot specified, not provided, Glycogen storage disease, type II
Conflicting interpretations of pathogenicity
(Oct 30, 2022)
criteria provided, conflicting interpretations
78.
GRCh37:
Chr17:78078421
GRCh38:
Chr17:80104622
GAAGlycogen storage disease, type II, Cardiovascular phenotypeConflicting interpretations of pathogenicity
(Sep 12, 2022)
criteria provided, conflicting interpretations
79.
GRCh37:
Chr17:78078422-78078429
GRCh38:
Chr17:80104623-80104630
GAAA14fsGlycogen storage disease, type IIPathogenic
(Feb 7, 2023)
reviewed by expert panel
FDA Recognized Database
80.
GRCh37:
Chr17:78078426
GRCh38:
Chr17:80104627
GAAA14VGlycogen storage disease, type IIUncertain significance
(Mar 3, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr17:78078427
GRCh38:
Chr17:80104628
GAAGlycogen storage disease, type IILikely benign
(Oct 5, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr17:78078427
GRCh38:
Chr17:80104628
GAAGlycogen storage disease, type IILikely benign
(Apr 22, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr17:78078428
GRCh38:
Chr17:80104629
GAAV15IGlycogen storage disease, type IIUncertain significance
(Aug 31, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr17:78078433
GRCh38:
Chr17:80104634
GAAGlycogen storage disease, type IILikely benign
(Jun 29, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr17:78078434
GRCh38:
Chr17:80104635
GAAA17SGlycogen storage disease, type IIUncertain significance
(Oct 13, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr17:78078434
GRCh38:
Chr17:80104635
GAAA17TGlycogen storage disease, type IIUncertain significance
(Aug 23, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr17:78078437
GRCh38:
Chr17:80104638
GAAL18FGlycogen storage disease, type IIUncertain significance
(Jul 20, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr17:78078439
GRCh38:
Chr17:80104640
GAAGlycogen storage disease, type IILikely benign
(Jul 6, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr17:78078439
GRCh38:
Chr17:80104640
GAAGlycogen storage disease, type IIUncertain significance
(Sep 16, 2021)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr17:78078440
GRCh38:
Chr17:80104641
GAAV19MCardiovascular phenotype, Glycogen storage disease, type IIUncertain significance
(Oct 30, 2022)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr17:78078440
GRCh38:
Chr17:80104641
GAAV19fsGlycogen storage disease, type IILikely pathogenic
(Mar 10, 2023)
reviewed by expert panel
FDA Recognized Database
92.
GRCh37:
Chr17:78078443
GRCh38:
Chr17:80104644
GAAS20TGlycogen storage disease, type IIUncertain significance
(Mar 13, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr17:78078444
GRCh38:
Chr17:80104645
GAAS20Cnot provided, Glycogen storage disease, type IIUncertain significance
(Oct 28, 2021)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr17:78078452
GRCh38:
Chr17:80104653
GAAT23Anot provided, Glycogen storage disease, type IIConflicting interpretations of pathogenicity
(Nov 3, 2022)
criteria provided, conflicting interpretations
95.
GRCh37:
Chr17:78078453
GRCh38:
Chr17:80104654
GAAT23IGlycogen storage disease, type IIUncertain significance
(Aug 30, 2021)
criteria provided, single submitter
96.
GRCh37:
Chr17:78078454
GRCh38:
Chr17:80104655
GAACardiovascular phenotype, Glycogen storage disease, type IIConflicting interpretations of pathogenicity
(Dec 4, 2022)
criteria provided, conflicting interpretations
97.
GRCh37:
Chr17:78078454
GRCh38:
Chr17:80104655
GAAGlycogen storage disease, type IILikely benign
(Oct 28, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr17:78078455
GRCh38:
Chr17:80104656
GAAA24Tnot provided, Glycogen storage disease, type II, Cardiovascular phenotype
Uncertain significance
(Aug 15, 2022)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr17:78078457
GRCh38:
Chr17:80104658
GAAGlycogen storage disease, type IILikely benign
(Feb 17, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr17:78078459
GRCh38:
Chr17:80104660
GAAA25Vnot provided, Glycogen storage disease, type IIUncertain significance
(Aug 30, 2021)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination